Trial intelligence / Profile preview

Pre-operative Nerve Blocks in Older Hip Fracture Patients

NCT02450045Terminated

Sponsor
University of Alberta
Start
Jun 2015
Primary completion
Jan 2020
Modality
Orthosteric Ligands
Countries
1
01

Overview

Open-label trial of ropivacaine in pain (2 arms), sponsored by University of Alberta. Primary endpoint: Feasibility of a definitive randomized controlled trial. Started Jun 2015; status: terminated.

02

Drugs

ropivacaine
03

Conditions

pain

Beyond the preview

Go deeper on NCT02450045.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02450045.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call